Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
This piece explains the meaning of nonce in blockchain, its role in securing proofs of work, and how it prevents duplicate blocks.
14,082 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
A Brooklyn rehab clinic case has public officials chasing a suspected scam spanning years. This article breaks down w...
Investors are watching Micron Technology closely as AI-driven demand reshapes memory markets. This guide explains whe...
Boone Capital just disclosed a fresh position in HealthEquity, raising questions about the stock's potential. This gu...
When a magnificent dividend stock drops 8%, it can feel painful. This guide shows how to separate price swings from l...
When the gates foundation sold remaining Microsoft stock, markets took note. This article explains why the move happe...
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Investors chasing a SpaceX IPO windfall risk turning luck into poor strategy. Experts warn the real lesson is risk ma...
A major investor moved a sizable stake in Hinge Health, triggering questions about timing and motives. This analysis ...
A leading hedge fund just disclosed a sizable new stake in Disc Medicine. This article breaks down what Disc Medicine...
Index funds and ETFs promise broad market exposure, but hidden concentration can undermine diversification. This guid...
A major institutional purchase in an international rotation ETF has market watchers buzzing. This article unpacks wha...